BioStem Technologies Inc. (BSEM)Accelerated into 2026 with Transformational Acquisition, Expanding into High-Value Surgical Markets While Showcasing Rare Profitability in Regenerative Medicine!
BioStem Technologies, Inc. (BSEM) entered 2026 with meaningful momentum following its acquisition of BioTissue Holdings’ surgical and wound care assets, a deal that significantly expands its reach into hospital and surgical settings.
By adding established products and an experienced salesforce, the company is diversifying beyond physician offices and tapping into higher-acuity applications like trauma, burns, and soft-tissue repair. This strategic shift not only broadens its total addressable market to an estimated $300–$350 million but also strengthens its commercial positioning in a healthcare system increasingly focused on outcomes and efficiency.
What truly sets BSEM apart is its ability to pair growth with financial discipline. Despite industry-wide reimbursement pressures, the company has delivered multiple profitable quarters, maintained exceptionally high gross margins, and preserved a strong cash position post-acquisition. Combined with clinical validation from its BioREtain® technology and a potential Nasdaq uplisting ahead, BSEM is evolving into a more institutional-quality story.
Zacks Small Cap Research highlights BSEM as a company where strong fundamentals and expanding market reach could justify significant upside to $25.50.
Caesars Surges on Buyout Buzz. Should Investors Take the Bet?
By Jennifer Ryan Woods. Publication Date: 3/17/2026.
Key Points
- Shares of Caesars Entertainment jumped nearly 20% after reports surfaced that billionaire Tilman Fertitta is in talks to acquire the company in a deal that could value the casino operator at about $7 billion, or roughly $34 per share.
- Investor sentiment had already started to improve following Caesars’ fourth-quarter earnings report, which beat revenue expectations and highlighted strength in the company’s digital segment, even though the company posted a wider-than-expected loss.
- Despite the recent rally, Caesars' stock remains far below its October 2021 peak near $120, as softer Las Vegas tourism, high debt of about $11.9 billion, and inconsistent earnings have weighed on the company.
- Special Report: Elon Musk already made me a "wealthy man"
In Las Vegas, there’s always a new bet to make, and lately investors are wagering on takeover speculation surrounding Caesars Entertainment Inc. (NASDAQ: CZR). Reports say billionaire Tilman Fertitta is in talks to acquire the casino giant in a deal that could value the company at roughly $7 billion, or about $34 per share.
With Caesars’ shares trading around $28 — roughly 20% below the reported buyout price — investors face a tough call: ride the momentum and play the upside or wait for clearer signals before placing their bets.
Buyout Rumors Send Shares Higher
Elon Musk already made me a "wealthy man" (Ad)
I Met Elon Musk "Face-to-Face"
During a private gathering of Wall Street elites, I was one of two people selected to speak with Elon personally.
As a result, my research now leads me to believe Elon will announce the SpaceX IPO on this date:
March 26, 2026. Circle it on your calendar.
I'm sharing an "access code" that lets anyone grab a pre-IPO stake before it happens. This is your invitation to the biggest wealth-building event of the decade.
Click Here to See how to Get Your "SpaceX Access Code"Rumors first surfaced in February after the Financial Times reported that Las Vegas-based Caesars was weighing takeover interest from several potential bidders, including Fertitta’s company, Fertitta Entertainment.
Fertitta already owns more than 10% of Wynn Resorts Ltd. (NASDAQ: WYNN), underscoring his growing influence in the casino industry. The Wall Street Journal later reported Fertitta’s offer topped a prior all-cash $33-per-share bid from Carl Icahn’s firm, which Caesars has not officially rejected, according to the report.
Shares of Caesars, which owns and manages more than 50 properties across the U.S., jumped nearly 20% following the takeover rumors and have continued to trend higher since then.
With shares still trading below the rumored deal price, the takeover buzz could leave room for further gains if negotiations progress. Even before the speculation began, the 12-month consensus price target of $33.65 suggested upside for the stock. But because much of the recent rally is tied to buyout chatter, shares could pull back quickly if a deal does not materialize.
Fourth-Quarter Earnings Spark Fresh Optimism for Caesars Stock
Sentiment had already begun to improve after Caesars’ Q4 2025 earnings report, released Feb. 17, which pleased Wall Street despite mixed results. Revenue of $2.92 billion rose 4.2% year over year and topped expectations by more than $22 million. On the bottom line, however, the company reported a loss of $1.23 per share, far wider than the 18-cent loss analysts had anticipated. The quarter marked the fourth consecutive quarter the company missed earnings estimates, and Caesars has reported a net loss in eight of the past nine quarters.
Management pointed to softness among leisure travelers, particularly midweek, and weather-related disruptions as factors that pressured recent results. The digital segment was a notable bright spot, generating a record $85 million in earnings before interest, taxes, depreciation and amortization (EBITDA).
Looking ahead, the company expects stronger net revenue and growth in its digital business. Caesars also anticipates lower capital spending and reduced cash interest expense, which should support free cash flow that management plans to use for share repurchases and further debt reduction.
That said, Caesars still carries a sizable debt load of about $11.9 billion and has a debt-to-equity ratio of 3.17, compared with about 1.9 for rival MGM Resorts International (NYSE: MGM).
Recent Rally Follows Years of Declines Amid Softening Las Vegas Tourism
Although the earnings report was mixed, investors reacted positively. Shares rose more than 4% ahead of the release and jumped an additional 15% in the days following. The earnings, coupled with takeover rumors the following week, helped push the stock up roughly 55% in about a month.
Still, the current price around $28 per share is a far cry from October 2021, when the stock hit a peak of nearly $120 amid the post-COVID travel surge and rapid growth in online sports betting. The stock later fell sharply as tourism slowed, and Caesars' market cap declined from roughly $25.5 billion to about $5.7 billion today.
Competitors MGM and Wynn have fared somewhat better over the last several years. While Caesars is down more than 72% over the past five years, Wynn is down roughly 26% and MGM less than 6%. Over the last year, Caesars is roughly flat, while MGM is up about 15% and Wynn more than 16%.
Analysts Still See Upside, But Short Sellers Remain Active
Despite the headwinds, analysts remain cautiously optimistic. The consensus rating is a Moderate Buy, with 12 Buy ratings, six Hold ratings and one Sell. Although several analysts trimmed their targets after the earnings report, the consensus price, just under $34, represents nearly 20% upside from the current level.
It’s notable, however, that short interest has stayed elevated, with roughly 15% to 18% of the float sold short in recent months — a sign that some investors remain skeptical about the company’s outlook.
If takeover talks progress, Caesars' shares could move closer to the rumored deal price. But without confirmation, the recent rally leaves the stock vulnerable to sharp pullbacks, making patience the safer approach for risk-averse investors.
The Silicon Squeeze: AI Pricing Power Lifts Chip Stocks
Reported by Jeffrey Neal Johnson. Originally Published: 3/26/2026.
Key Points
- Recent price hikes reflect a fundamental shift in negotiating power toward the semiconductor designers due to unprecedented AI-driven demand.
- For Advanced Micro Devices, this pricing strength validates its technological leadership and accelerates strategic growth in the lucrative data center market.
- Intel's reassertion of pricing power provides essential funding for its ambitious manufacturing and foundry turnaround strategy.
- Special Report: Elon Musk already made me a "wealthy man"
A powerful rally in the shares of semiconductor giants Intel (NASDAQ: INTC) and Advanced Micro Devices (NASDAQ: AMD) is sending a clear message to investors. Recent single-day gains — over 7% for Intel and more than 6% for AMD — were not driven by rumors; they were market reactions to credible reports that both companies are planning price increases for their core central processing units (CPUs).
These price hikes are far more than routine inflation adjustments. They signal a fundamental power shift within the technology supply chain. For years, large PC and server vendors wielded immense negotiating power over their suppliers. That era appears to be ending. Driven by an unprecedented wave of demand for computational power, chip designers are now in the driver's seat. This newfound leverage is a durable catalyst for their stocks and is reshaping the economics of the broader tech industry.
How AI Fueled a Demand Firestorm
Elon Musk already made me a "wealthy man" (Ad)
I Met Elon Musk "Face-to-Face"
During a private gathering of Wall Street elites, I was one of two people selected to speak with Elon personally.
As a result, my research now leads me to believe Elon will announce the SpaceX IPO on this date:
March 26, 2026. Circle it on your calendar.
I'm sharing an "access code" that lets anyone grab a pre-IPO stake before it happens. This is your invitation to the biggest wealth-building event of the decade.
Click Here to See how to Get Your "SpaceX Access Code"The force behind this industry-wide supply crunch can be distilled into two letters: AI — the global tech sector is engaged in an artificial intelligence (AI) arms race. Tech titans and enterprises across industries are investing billions to build the massive data center infrastructure needed to power generative AI and large language models. That investment has ignited a surge in demand for the high-performance processors at the heart of these systems.
This is not a simple uptick in orders; it's a structural market shift. The complexity of modern AI models requires a density of computing power that is orders of magnitude greater than traditional cloud workloads. As tech giants aggressively compete to secure advanced server CPUs and AI accelerators, they consume a large portion of the world's finite chip manufacturing capacity. That creates a supply squeeze that cascades across market segments, tightening availability for both everyday PCs and corporate servers. The dynamic has fundamentally increased the value of the underlying silicon, giving chip designers pricing leverage not seen in years.
From Leverage to Profit: The New Margin Reality
This newfound pricing power is a meaningful tailwind for both Intel and AMD, and it reinforces each company's distinct strategic narrative — strengthening the bull case for both.
AMD: An Offensive Strike From a Position of Power
For AMD, the ability to command higher prices is an offensive advantage. AMD has executed its strategy effectively in the lucrative data center market, where its EPYC server processors have steadily chipped away at Intel's market share.
With data center revenues recently surging by over 39% year-over-year and a healthy gross margin around 51.5%, AMD is already performing strongly.
A price increase acts as an accelerant: additional revenue flows largely to the bottom line, expanding margins and generating significant free cash flow.
That cash is critical ammunition in AMD's competition with NVIDIA (NASDAQ: NVDA) in the AI accelerator space, enabling greater investment in its Instinct GPU lineup.
Being able to pass on higher prices to hardware customers validates AMD's technological leadership and underscores the essential role its products play in the modern data center.
Intel: A Critical Victory Funding a Historic Turnaround
For Intel, this pricing power is an urgently needed strategic and financial win. Intel is in the midst of a costly, multi-year turnaround.
Intel's IDM 2.0 strategy — a plan to regain manufacturing leadership and build a foundry business to compete with global leader Taiwan Semiconductor Manufacturing (NYSE: TSM) — requires tens of billions of dollars in capital investment. A primary investor concern has been the sheer cost of this ambition. These price increases provide a crucial financial lifeline.
The incremental high-margin revenue from its established CPU business offers a non-dilutive source of funding for the company's future investments.
It also demonstrates that Intel still commands significant authority in the PC and enterprise markets and that its products remain integral enough that customers will accept higher prices. This reassertion of pricing power strengthens Intel's long-term investment case.
A Clear Forecast for a Shifting Market
A fundamental value shift is underway in the tech sector. Profitability is flowing upstream from hardware assemblers to the semiconductor designers who own the core intellectual property. This re-emergence of pricing power looks less like a fleeting event and more like a durable catalyst, supporting a constructive outlook for Intel and AMD.
For investors, the next major checkpoint will be the companies' upcoming earnings calls, which should provide the first concrete data on gross margin expansion. Looking ahead, the keys to long-term success will be AMD's ability to sustain its data center momentum and Intel's disciplined execution of its foundry roadmap. In this AI-driven era, the companies that design the essential building blocks of our digital world are increasingly in control.
to bring you the latest market-moving news.
This message is a sponsored message from Huge Alerts, a third-party advertiser of TickerReport and MarketBeat.
This message is a paid advertisement for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency and Huge Alerts. American Consumer News, LLC dba TickerReport dba MarketBeat receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $14,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Sideways Frequency or Huge Alerts. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts' website for additional information about the relationship between Huge Alerts and BioStem Technologies Inc. (OTC: BSEM).
Contact Us | Unsubscribe
Copyright 2006-2026 MarketBeat Media, LLC dba TickerReport. All rights reserved.
345 N Reid Place, Suite 620, Sioux Falls, South Dakota 57103. USA..
0 Response to "Small-cap MedTech with multiple profitable quarters and $25.50 upside"
Post a Comment